Parkinsonism & Related Disorders
Volume 16, Issue 3 , Pages 202-207 , March 2010

Association between the dose of dopaminergic medication and the behavioral disturbances in Parkinson disease

  • Jee-Young Lee

      Affiliations

    • Department of Neurology, Inje University Ilsan Paik Hospital, Goyang, South Korea
    • ,
  • Jong-Min Kim

      Affiliations

    • Department of Neurology, Seoul National University Bundang Hospital, Seongnam, South Korea
    • ,
  • Jae Woo Kim

      Affiliations

    • Department of Neurology, Dong-A University Medical Center, Busan, South Korea
    • ,
  • Jinwhan Cho

      Affiliations

    • Department of Neurology, Seoul National University Boramae Hospital, Seoul, South Korea
    • ,
  • Won Yong Lee

      Affiliations

    • Department of Neurology, Samsung Medical Center, Seoul, South Korea
    • ,
  • Han-Joon Kim

      Affiliations

    • Department of Neurology, Clinical Research Institute and Movement Disorder Center, Seoul National University Hospital, Seoul, South Korea
    • ,
  • Beom S. Jeon

      Affiliations

    • Department of Neurology, Clinical Research Institute and Movement Disorder Center, Seoul National University Hospital, Seoul, South Korea
    • Corresponding Author InformationCorresponding author. BK21, Neuroscience Research Institute, Seoul National University College of Medicine, Department of Neurology, Clinical Research Institute and Movement Disorders Center, Seoul National University Hospital, Seoul 110-744, South Korea. Tel.: +82 2 2072 2876; fax: +82 2 3672 7553.

Received 9 July 2009 ,Revised 30 November 2009 ,Accepted 1 December 2009.

References 

  1. Lim SY, Evans AH, Miyasaki JM. Impulse control and related disorders in Parkinson's disease. Ann N Y Acad Sci. 2008;1142:85–107
  2. Lees AJ. The dopamine dysregulation syndrome. Mov Disord. 2008;23:1332
  3. Evans AH, Katzenschlager R, Paviour D, O'Sullivan JD, Appel S, Lawrence AD, et al. Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome. Mov Disord. 2004;19:397–405
  4. Giovannoni G, O'Sullivan JD, Turner K, Mancon AJ, Lees AJ. Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatr. 2000;68:423–428
  5. Voon V, Fox SH. Medication-related impulse control and repetitive behaviors in Parkinson disease. Arch Neurol. 2007;64:1089–1096
  6. Giladi N, Weitzman N, Schreiber S, Shabtai H, Peretz C. New onset heightened interest or drive for gambling, shopping, eating or sexual activity in patients with Parkinson's disease: the role of dopamine agonist treatment and age at motor symptom onset. J Psychopharmacol. 2007;21:501–506
  7. Weintraub D, Siderowf AD, Potenza MN, Goveas J, Morales KH, Duda JE, et al. Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol. 2006;63:969–973
  8. Weiss HD, Hirsch E, Sweringen L, Anderson K, Goldstein S, Grill S, et al. Impulse control disorders in Parkinson's disease patients followed in a community-based neurology practice. Mov Disord. 2008;23(Suppl. 1):S281;the poster number 862
  9. Voon V, Hassan K, Zurowski M, Duff-Canning S, de Souza M, Fox S, et al. Prospective prevalence of pathologic gambling and medication association in Parkinson disease. Neurology. 2006;66:1750–1752
  10. Voon V, Hassan K, Zurowski M, de Souza M, Thomsen T, Fox S, et al. Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology. 2006;67:1254–1257
  11. Avanzi M, Baratti M, Cabrini S, Uber E, Brighetti G, Bonfa F. Prevalence of pathological gambling in patients with Parkinson's disease. Mov Disord. 2006;21:2068–2072
  12. Miyasaki JM, Al Hassan K, Lang AE, Voon V. Punding prevalence in Parkinson's disease. Mov Disord. 2007;22:1179–1181
  13. Lawrence AJ, Blackwell AD, Barker RA, Spagnolo F, Clark L, Aitken MR, et al. Predictors of punding in Parkinson's disease: results from a questionnaire survey. Mov Disord. 2007;22:2339–2345
  14. Voon V, Potenza MN, Thomsen T. Medication-related impulse control and repetitive behaviors in Parkinson's disease. Curr Opin Neurol. 2007;20:484–492
  15. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55:181–184
  16. Lee JY, Lee EK, Park SS, Lim JY, Kim HJ, Kim JS, et al. Association of DRD3 and GRIN2B with impulse control and related behaviors in Parkinson disease. Mov Disord. 2009;24:1803–1810
  17. Grosset KA, Grosset DG. Proposed dose equivalence for rapid switching between dopamine agonists in Parkinson's disease. Clin Ther. 2006;28:1063–1064
  18. Hobson DE, Lang AE, Martin WR, Razmy A, Rivest J, Fleming J. Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian movement disorders group. JAMA. 2002;287:455–463
  19. Christenson GA, Faber RJ, de Zwaan M, Raymond NC, Specker SM, Ekern MD, et al. Compulsive buying: descriptive characteristics and psychiatric comorbidity. J Clin Psychiatry. 1994;55:5–11
  20. Park S, Cho MJ, Jeon HJ, Lee HW, Bae JN, Park JI, et al. Prevalence, clinical correlations, comorbidities, and suicidal tendencies in pathological Korean gamblers: results from the Korean epidemiologic catchment area study. Epub ahead of print Soc Psychiat Epidemiol. 2009 Jul 28;
  21. Westermeyer J, Canive J, Garrard J, Thuras P, Thompson J. Lifetime prevalence of pathological gambling among American Indian and Hispanic American Veterans. Am J Public Health. 2005;95:860–866
  22. Brewer JA, Potenza MN. The neurobiology and genetics of impulse control disorders: relationships to drug addictions. Biochem Pharmacol. 2008;75:63–75
  23. Wolters EC, van der Werf YD, van den Heuvel OA. Parkinson's disease- related disorders in the impulsive-compulsive spectrum. J Neurol. 2008;25(Suppl. 5):45–56
  24. Winstanley CA, Theobald DE, Dalley JW, Robbins TW. Interactions between serotonin and dopamine in the control of impulsive choice in rats: therapeutic implications for impulse control disorders. Neuropsychopharmacology. 2005;30:669–682
  25. Isaias IU, Siri C, Cilia R, De Gaspari D, Pezzoli G, Antonini A. The relationship between impulsivity and impulse control disorders in Parkinson's disease. Mov Disord. 2008;23:411–415
  26. Gallagher DA, O'sullivan SS, Evans AH, Lees AJ, Schrag A. Pathological gambling in Parkinson's disease: risk factors and differences from dopamine dysregulation. An analysis of published case series. Mov Disord. 2007;22:1757–1763
  27. Voon V, Thomsen T, Miyasaki JM, de Souza M, Shafro A, Fox SH, et al. Factors associated with dopaminergic drug–related pathological gambling in Parkinson disease. Arch Neurol. 2007;64:212–216

☆ Disclosure: The authors have no conflict of interest.

☆☆ The review of this paper was entirely handled by an Associate Editor, En-King Tan.

PII: S1353-8020(09)00305-8

doi: 10.1016/j.parkreldis.2009.12.002

Parkinsonism & Related Disorders
Volume 16, Issue 3 , Pages 202-207 , March 2010

Article Tools